Improving Health through Rehabilitation Robotic Technology (R43/R44)

The summary for the Improving Health through Rehabilitation Robotic Technology (R43/R44) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Improving Health through Rehabilitation Robotic Technology (R43/R44): The purpose of this funding opportunity announcement (FOA) is to encourage the translation of rehabilitation robotic technology to assist health care providers and individuals in need of rehabilitation.
Federal Grant Title: Improving Health through Rehabilitation Robotic Technology (R43/R44)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HD-15-001
Type of Funding: Grant
CFDA Numbers: 93.865
CFDA Descriptions: Child Health and Human Development Extramural Research
Current Application Deadline: Nov 13, 2014
Original Application Deadline: Nov 13, 2014
Posted Date: August 19th, 2014
Creation Date: Aug 19, 2014
Archive Date: Dec 14, 2014
Total Program Funding: $900,000
Maximum Federal Grant Award: none
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following:
Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. A small business concern is one that, at the time of award of Phase I and Phase II, meets all of the following criteria:

1. Is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor;

2. Is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there must be less than 50 percent participation by foreign business entities in the joint venture;

3. (i) SBIR and STTR. Be a concern which is more than 50 percent directly owned and controlled by one or more individuals (who are citizens or permanent resident aliens of the United States), other business concerns (each of which is more than 50 percent directly owned and controlled by individuals who are citizens or permanent resident aliens of the United States), or any combination of these; OR

(ii) SBIR-only. Be a concern which is more than 50 percent owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these. No single venture capital operating company, hedge fund, or private equity firm may own more than 50 percent of the concern; OR

(iii) SBIR and STTR. Be a joint venture in which each entity to the joint venture must meet the requirements set forth in paragraph 3 (i) or 3 (ii) of this section. A joint venture that includes one or more concerns that meet the requirements of paragraph (ii) of this section must comply with § 121.705(b) concerning registration and proposal requirements.

4. Has, including its affiliates, not more than 500 employees.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-15-001.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...
National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 C...
Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescen...
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
Biological Testing Facility (X01 Clinical Trial Not Allowed)
Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com